Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer

Silvia Valtorta, Sara Belloli, Francesca Sanvito, Valeria Masiello, Giuseppe Di Grigoli, Cristina Monterisi, Ferruccio Fazio, Maria Picchio and Rosa Maria Moresco
Journal of Nuclear Medicine July 2013, 54 (7) 1106-1112; DOI: https://doi.org/10.2967/jnumed.112.111120
Silvia Valtorta
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Belloli
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Sanvito
4Mouse HistoPathology Unit, Department of Pathology San Raffaele Scientific Institute, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valeria Masiello
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Di Grigoli
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Monterisi
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferruccio Fazio
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Picchio
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Maria Moresco
1IBFM-CNR, Segrate, Milan, Italy
2Fondazione Tecnomed and Department of Health Sciences, University of Milan-Bicocca, Milan, Italy
3Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (7)
Journal of Nuclear Medicine
Vol. 54, Issue 7
July 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer
Silvia Valtorta, Sara Belloli, Francesca Sanvito, Valeria Masiello, Giuseppe Di Grigoli, Cristina Monterisi, Ferruccio Fazio, Maria Picchio, Rosa Maria Moresco
Journal of Nuclear Medicine Jul 2013, 54 (7) 1106-1112; DOI: 10.2967/jnumed.112.111120

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer
Silvia Valtorta, Sara Belloli, Francesca Sanvito, Valeria Masiello, Giuseppe Di Grigoli, Cristina Monterisi, Ferruccio Fazio, Maria Picchio, Rosa Maria Moresco
Journal of Nuclear Medicine Jul 2013, 54 (7) 1106-1112; DOI: 10.2967/jnumed.112.111120
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2
  • VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
  • Google Scholar

More in this TOC Section

  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
Show more Basic Science Investigations

Similar Articles

Keywords

  • tumor hypoxia
  • PET imaging
  • 18F-FAZA
  • 64Cu-ATSM
SNMMI

© 2025 SNMMI

Powered by HighWire